It is important to determine which patients require screening for thrombophilia, and subsequently which patients require treatment. Certain clinical scenarios may warrant thrombophilia screening. Unnecessary thrombophilia screening can lead to increased costs
Thrombophilia cost-effectiveness of therapy
Deep vein thrombosis cost-effectiveness of therapy
Heparin-induced thrombocytopenia cost-effectiveness of therapy
Thrombophilia primary prevention
Cilostazol detailed information
Thrombosis risk stratification
Hemophilia A cost-effectiveness of therapy
Thrombophilia secondary prevention